HOME >> MEDICINE >> NEWS
Drug to treat ADHD has similar effect on children with reading disorders

The drug methylphenidate (brand name Ritalin) increased activity in brains of children with attention-deficit/hyperactivity disorder (ADHD) as well as those with a reading disorder, researchers at Yale report in the American Journal of Psychiatry.

"During a test of divided attention, Ritalin increased activation in the basal ganglia, a structure of the brain involved in cognition and behavior," said first author Keith Shafritz, former graduate student in the interdepartmental Neuroscience Program at Yale and now a research associate at Duke University Medical Center. "We saw this activation in children with ADHD and those with reading disorder."

The study used functional magnetic resonance imaging (fMRI) to analyze the effect of the drug on brain function. Researchers found that adolescents with ADHD or reading disorder who were on placebo (not medicated) had less activation of the basal ganglia than a group of healthy participants. When the same participants received Ritalin, the drug normalized the activation, which relates to the amount of blood flow to a specific brain region in response to a cognitive task.

ADHD is characterized by inattention, but previous neuroimaging studies have examined the brain dysfunction associated with impulsivity. "This is one of few studies that used a test for attention rather than a cognitive test for impulsivity," said Shafritz. "It is also the first study, using fMRI to find that the attention circuitry in the brain is directly affected by ADHD."

The 27 study participants, ages 14 to 18 with either ADHD or reading disorder, were randomly assigned to receive Ritalin first or placebo first and didn't know to which group they were assigned. While in the MRI, the participants were given auditory or visual performance tasks to decide whether they saw or heard a real English word or a nonsense word. Their results were compared to a group of 14 healthy adolescents who were not given Rital
'"/>

Contact: Karen N. Peart
karen.peart@yale.edu
203-432-1326
Yale University
13-Dec-2004


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Chronic pain treatments more effective when taken together, new study shows
4. Brain activity prior to treatment flags vulnerability to antidepressant side effects
5. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
6. OHSU scientists test medication to treat involuntary weight loss
7. Cultural and social factors influence prostate cancer treatment
8. Research offers hope of new treatments for liver damage
9. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
10. Risky surgery not always necessary to treat cervical disease
11. Stanford patient is first to test new treatment for peripheral arterial disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... New York (PRWEB) , ... August 23, 2017 , ... ... intellectual and developmental disabilities (I/DD), has launched a groundbreaking LGBTQ community organization for people ... just the first organization of its kind in the state of New Jersey – ...
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... Jachimowicz ... California, office at 1530 The Alameda, Suite 115. The office is located between Schiele ... the contact information remains the same. Clients can still call the office at 408-246-5500. ...
(Date:8/23/2017)... Texas (PRWEB) , ... August 23, 2017 , ... This ... denied claims firms in Texas. Founded by Bill Voss, the firm grew quickly and ... decade and a half of helping clients get the money they deserve from their ...
(Date:8/23/2017)... ... 2017 , ... Loyale Healthcare today announced the ... joins other recent high-profile hires including Frank Massi, Chief Revenue Officer and Shirley ... helping physician practices and hospitals automate their clinical and financial processes to gain ...
(Date:8/23/2017)... ... 2017 , ... Drs. Steven White and Brad Haines are pleased to announce ... of this offer, valued at more than $300 per year, new patients can enjoy ... patients receive a complimentary professional whitening procedure. , Stained or yellowed tooth enamel ...
Breaking Medicine News(10 mins):
(Date:8/23/2017)... 23, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... health and big data solutions, announced today that ... with domestic and non-U.S. investors for the sale ... shares of the Company,s newly designated Series B ... Current shareholders accounted for 58% of the securities ...
(Date:8/23/2017)... -- Epygenix Therapeutics, Inc., a privately held biopharmaceutical company developing ... epilepsy, announced today that the U.S. Food and Drug ... the treatment of patients with Dravet Syndrome. Dravet Syndrome ... of the Food, Drug, and Cosmetic Act. ... of epilepsy, begins in the first year of life ...
(Date:8/18/2017)... , Aug. 18, 2017  Nortis today announced the awarding of a $688K ... for the third year of a Small Business Innovation ... Institute of Neurological Disorders and Stroke (NINDS).?  ... Nortis ParVivo Chip ... ...
Breaking Medicine Technology:
Cached News: